2008 has seen no decrease in the opportunities available for outsourcing drug discovery, for a number of reasons. New technologies increase the number of targets and accelerate the identification of active compounds. There is increasing pressure to develop new lead compounds due to the near-term loss of patent protection for many drug product. And there is also pressure to reduce the time spent in drug discovery and to bring drugs to market sooner, as well as the ever-present cost considerations. Kalorama Information's Outsourcing in Drug Discovery offers unparalleled discussion of the drug discovery outsourcing market. It presents viewpoints from both customers and suppliers. Segments, size, and growth of the market are presented. The trend toward the increased use of offshore suppliers is covered in detail. The report also provides profiles of 23 suppliers, representative of those active in this market. Segments covered in this report include:
In addition to market data and forecasts, the report covers issues such as:
This report looks offshore at outsourcing suppliers based in three major areas: India, China, and Eastern Europe. The relative advantages each country provides are contrasted with some of their limitations. The report asses which projects are moving to which suppliers and why. Related Reports: The Worldwide Market for Anti-Infectives (Antifungals, Antibacterials and Antivirals)Oct 1, 2009 - KLI2435380 - $3,500.00 The World Market for Biosimilars and the Potential for US Follow-on Biologics Aug 1, 2009 - KLI2402283 - $3,700.00 Vaccines 2009: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry Jun 1, 2009 - KLI2155319 - $3,995.00 Rx to OTC Switches 2009 May 1, 2009 - KLI2196300 - $3,500.00 World Veterinary Health Products (Animal Pharmaceuticals, Vaccines, OTC and Performance Enhancers) May 1, 2009 - KLI1829596 - $3,500.00 Pharmaceutical Markets in India Apr 1, 2009 - KLI2155338 - $1,295.00 Clinical Nutrition Products: World Markets, 3rd Edition Feb 1, 2009 - KLI2089645 - $3,795.00 Pharmaceutical Markets in Russia Jan 1, 2009 - KLI2074032 - $995.00 Pharmaceutical Outsourcing Post-Launch : Contract Manufacturing, Biomanufacturing and Sales, 3rd Edition Jan 1, 2009 - KLI1646605 - $3,500.00 Pharmaceutical Markets in the Middle East (Opportunities, Key Players, Trends in Egypt, Jordan, Israel, Saudi Arabia and UAE) Nov 1, 2008 - KLI1646593 - $3,300.00 |
800.298.5603
Int'l: +1.240.747.3096
Questions?
Contact a research specialist >
Most Popular Research
Outsourcing in Drug Discovery: The Contract Research (CRO) Market, 3rd Edition
Clinical Nutrition Products: World Markets, 3rd Edition
World Veterinary Health Products (Animal Pharmaceuticals, Vaccines, OTC and Performance Enhancers)
Vaccines: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry
Vaccines 2009: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry
What's Next in Vaccines? HIV, Malaria, MRSA, and 30 Other Vaccine Targets in the 2010-2016 Pipeline
|
|||||||||
|
Privacy Policy
|
Terms and Conditions
|
Site Map
|
Return Policy
|
Press
|
Help FAQs
|